Stock UniverseDerived research view · source repositories remain read-only

BioNTech SE (BNTX)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
High
Selection Score
42.69
Global Rank
196
Market Cap
27.66B
Latest Close
88.08
RS Composite
-12.09% · G#2231

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-7.54%
3M
-13.22%
6M
-8.94%
1Y
-20.75%
3Y
-16.18%
5Y
-56.25%
10Y
526.73%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 836.99K · 30-day average: 900.37K · Max drawdown over stored range: -82.25%

Research Snapshot

Relative Strength vs SPX

RS Composite-12.09%
20D RS-5.95%
60D RS-12.01%
120D RS-15.25%
Global RS Rank2231 · 33.50% percentile
Qualified+ RS Rank840 · 33.23% percentile
Group ScopeQualified+
Primary RS Rank223 · 51.31% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank12 / 701
Primary Percentile98.43
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for BNTX.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue482.318976.717310.638192751.12869.9
Revenue Growth (YoY)344.107%3834.626%-8.78%-77.938%-27.963%4.318%
Gross Profit42316065.214315.63219.22209.82258.6
Operating Income-321.414846.511918.3971.8-1285.5-1266.7
Free Cash Flow-79.5762.213248.25121.3-78.8280.9
Free Cash Flow Per Share-0.322.93553.03521.101-0.3281.162
EPS (Diluted) GAAP0.0639.6337.773.83-2.77-4.700455
EPS Growth9600%65950.0%-4.693%-89.86%9600%
EPS Non-GAAP
Gross Margin87.705%84.658%82.698%84.294%80.324%78.7%
Operating Margin-66.639%78.235%68.85%25.446%-46.727%-44.137%
Profit Margin3.152%54.238%54.501%24.36%-24.183%-39.587%
Free Cash Flow Margin-16.484%4.017%76.532%134.101%-2.864%9.788%
Shares Outstanding (Diluted)248.5259.7249.8242.7240.4241.7
Shares Change (YoY)17.494%4.507%-3.812%-2.842%-0.948%0.541%

SEC Quarterly Fundamentals

No processed quarterly rows for BNTX.